Multicenter prospective phase II study of venetoclax in patients with previously treated Waldenstrom macroglobulinemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2019.09.060 ◽

2019 ◽

Vol 19 (10) ◽

pp. e39-e40 ◽

Author(s):

Jorge Castillo ◽

John Allan ◽

Tanya Siddiqi ◽

Ranjana Advani ◽

Andrew Keezer ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia ◽

Prospective Phase ◽

Previously Treated

Download Full-text

A Multicenter Phase II Study of Single-Agent Enzastaurin in Previously Treated Waldenström Macroglobulinemia

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-12-0181 ◽

2012 ◽

Vol 18 (18) ◽

pp. 5043-5050 ◽

Author(s):

Irene M. Ghobrial ◽

Philippe Moreau ◽

Brianna Harris ◽

Tiffany Poon ◽

Eric Jourdan ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Single Agent ◽

Waldenström Macroglobulinemia ◽

Multicenter Phase ◽

Waldenstrom Macroglobulinemia ◽

Previously Treated

Download Full-text

Activity of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) previously treated with ketoconazole (keto): A prospective phase II study from the Prostate Cancer Clinical Trials Consortium.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.5039 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5039-5039 ◽

Author(s):

Won Kim ◽

John Wilton ◽

Li Zhang ◽

Amy M. Lin ◽

Lawrence Fong ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Phase Ii ◽

Phase Ii Study ◽

Abiraterone Acetate ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Prospective Phase ◽

Previously Treated

Download Full-text

857TiP An open-label, multicenter, phase II study of CLR 131 in patients with relapsed or refractory (R/R) select B-cell malignancies (CLOVER-1) and expansion cohort in patients with waldenstrom macroglobulinemia (CLOVER-WaM)

Annals of Oncology ◽

10.1016/j.annonc.2021.08.150 ◽

2021 ◽

Vol 32 ◽

pp. S784-S785

Author(s):

S. Ailawadhi ◽

A. Chanan-Khan ◽

J. Peterson ◽

P. Stiff ◽

E. Ibrahim ◽

...

Keyword(s):

B Cell ◽

Phase Ii ◽

Phase Ii Study ◽

B Cell Malignancies ◽

Waldenström Macroglobulinemia ◽

Multicenter Phase ◽

Waldenstrom Macroglobulinemia ◽

Expansion Cohort

Download Full-text

Pemetrexed for previously treated patients with metastatic gastric cancer: a prospective phase II study

British Journal of Cancer ◽

10.1038/bjc.2014.607 ◽

2014 ◽

Vol 112 (2) ◽

pp. 266-270 ◽

Author(s):

D S Zhang ◽

Y Jin ◽

H Y Luo ◽

Z Q Wang ◽

M Z Qiu ◽

...

Keyword(s):

Gastric Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Metastatic Gastric Cancer ◽

Prospective Phase ◽

Previously Treated Patients ◽

Previously Treated

Download Full-text

A Single-Arm, Phase II Study of the Anti-Blys Monoclonal Antibody Belimumab in Symptomatic Waldenstrom Macroglobulinemia

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2013.04.006 ◽

2013 ◽

Vol 13 (5) ◽

pp. 575-578 ◽

Author(s):

Mark Bishton ◽

Andrew Spencer ◽

Michael Dickinson ◽

David Ritchie

Keyword(s):

Monoclonal Antibody ◽

Phase Ii ◽

Phase Ii Study ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

5.44 Consolidation Therapy with Subcutaneous Alemtuzumab after Induction Treatment with Oral Fludarabine and Cyclophosphamide in Previously Untreated Patients Aged 65-70 years with Advanced Stage CLL: Final Results of a Phase II Study from the French Cooperative Group on Chronic Lymphocytic Leukemia and Waldenstrom Macroglobulinemia (FCG-CLL/WM)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2011.09.198 ◽

2011 ◽

Vol 11 ◽

pp. S273-S275

Author(s):

Alain Delmer ◽

Olivier Tournilhac ◽

Stéphane Leprêtre ◽

Bruno Cazin ◽

Pierre Feugier ◽

...

Keyword(s):

Chronic Lymphocytic Leukemia ◽

Phase Ii ◽

Phase Ii Study ◽

Lymphocytic Leukemia ◽

Induction Treatment ◽

Cooperative Group ◽

Advanced Stage ◽

Consolidation Therapy ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Cisplatin plus gemcitabine in previously treated squamous cell carcinoma of the cervix: A phase II study of the Gynecologic Oncology Group

Yearbook of Obstetrics Gynecology and Women s Health ◽

10.1016/s1090-798x(08)70269-8 ◽

2007 ◽

Vol 2007 ◽

pp. 386-387

Author(s):

B.J. Monk

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Gynecologic Oncology ◽

Gynecologic Oncology Group ◽

Oncology Group ◽

Previously Treated

Download Full-text

Faculty Opinions recommendation of Rituximab and subcutaneous 2-chloro-2'-deoxyadenosine combination treatment for patients with Waldenstrom macroglobulinemia: clinical and biologic results of a phase II multicenter study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4957957.4890058 ◽

2010 ◽

Author(s):

Xavier Leleu

Keyword(s):

Phase Ii ◽

Multicenter Study ◽

Combination Treatment ◽

Waldenström Macroglobulinemia ◽

Waldenstrom Macroglobulinemia

Download Full-text

Faculty Opinions recommendation of Isavuconazole as Primary Anti-Fungal Prophylaxis in Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome: An Open-Label, Prospective, Phase II Study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.737669231.793578956 ◽

2020 ◽

Author(s):

Livio Pagano

Keyword(s):

Acute Myeloid Leukemia ◽

Myelodysplastic Syndrome ◽

Phase Ii ◽

Myeloid Leukemia ◽

Phase Ii Study ◽

Prospective Phase ◽

Anti Fungal ◽

Download Full-text

Final survival results for the LURET phase II study of vandetanib in previously treated patients with RET-rearranged advanced non-small cell lung cancer

Lung Cancer ◽

10.1016/j.lungcan.2021.03.002 ◽

2021 ◽

Vol 155 ◽

pp. 40-45

Author(s):

Kiyotaka Yoh ◽

Takashi Seto ◽

Miyako Satouchi ◽

Makoto Nishio ◽

Noboru Yamamoto ◽

...

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell Lung ◽

Previously Treated Patients ◽

Previously Treated ◽

Download Full-text